Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.33 - $12.0 $6,694 - $243,420
20,285 New
20,285 $6,000
Q3 2022

Nov 14, 2022

SELL
$0.68 - $11.25 $3,937 - $65,137
-5,790 Reduced 22.21%
20,285 $15,000
Q2 2022

Aug 15, 2022

SELL
$0.81 - $3.43 $78,236 - $331,296
-96,588 Reduced 78.74%
26,075 $24,000
Q1 2022

May 11, 2022

SELL
$2.27 - $4.13 $102 - $185
-45 Reduced 0.04%
122,663 $423,000
Q4 2021

Feb 11, 2022

BUY
$3.37 - $6.87 $6,740 - $13,740
2,000 Added 1.66%
122,708 $481,000
Q3 2021

Nov 12, 2021

BUY
$5.78 - $7.86 $71,764 - $97,589
12,416 Added 11.47%
120,708 $809,000
Q2 2021

Aug 11, 2021

BUY
$7.82 - $12.44 $3,331 - $5,299
426 Added 0.39%
108,292 $846,000
Q1 2021

May 13, 2021

SELL
$9.33 - $14.05 $35,892 - $54,050
-3,847 Reduced 3.44%
107,866 $1.36 Million
Q4 2020

Feb 09, 2021

BUY
$8.48 - $12.23 $83,434 - $120,330
9,839 Added 9.66%
111,713 $1.05 Million
Q3 2020

Nov 12, 2020

SELL
$9.99 - $14.41 $3,816 - $5,504
-382 Reduced 0.37%
101,874 $1.11 Million
Q2 2020

Aug 12, 2020

BUY
$12.28 - $17.63 $411,723 - $591,098
33,528 Added 48.78%
102,256 $1.41 Million
Q1 2020

May 06, 2020

BUY
$11.31 - $18.26 $19,260 - $31,096
1,703 Added 2.54%
68,728 $913,000
Q4 2019

Feb 14, 2020

BUY
$6.44 - $14.21 $76,339 - $168,445
11,854 Added 21.49%
67,025 $937,000
Q3 2019

Nov 07, 2019

SELL
$4.6 - $8.46 $51,644 - $94,980
-11,227 Reduced 16.91%
55,171 $363,000
Q2 2019

Aug 12, 2019

BUY
$5.83 - $8.42 $146,391 - $211,426
25,110 Added 60.82%
66,398 $554,000
Q1 2019

May 14, 2019

BUY
$4.02 - $5.81 $17,824 - $25,761
4,434 Added 12.03%
41,288 $239,000
Q4 2018

Feb 11, 2019

BUY
$3.35 - $5.68 $33,754 - $57,231
10,076 Added 37.63%
36,854 $149,000
Q3 2018

Nov 09, 2018

BUY
$4.07 - $6.25 $1,391 - $2,137
342 Added 1.29%
26,778 $0
Q2 2018

Aug 06, 2018

BUY
$5.19 - $9.71 $137,202 - $256,693
26,436 New
26,436 $138,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.